Multivalent meningococcal polysaccharide-protein conjugate vaccine
The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria meningitidis. The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purifie...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
14.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria meningitidis. The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides from Neisseria meningitidis serogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety of N. meningitidis strains in children as well as adults. |
---|---|
Bibliography: | Application Number: US201816172960 |